- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Oncology
- Nephrology
- Neurology
- Pulmonology
Impetigo Secondary to Chickenpox
Impetigo developed on the face of a 7-year-old boy who had chickenpox. Thepatient was given a 10-day course of oral cephalexin and mupirocin ointment;the infection resolved promptly.
Impetigo developed on the face of a 7-year-old boy who had chickenpox. Thepatient was given a 10-day course of oral cephalexin and mupirocin ointment;the infection resolved promptly.As many as 10,000 children and adolescents are hospitalized each yearbecause of chickenpox and its complications, and 43 of these youngsters die.1A significant decrease in varicella-caused morbidity is expected with wideruse of the chickenpox vaccine.
References:
REFERENCE:
1.
Centers for Disease Control and Prevention. Varicella-related deaths among children-United States,1997.
MMWR.
1998;47:365-368.(Case and photograph courtesy of Dr Robert P. Blereau.)
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.
